Effects of DA and D1, D2 receptors agonists on spike properties of FS interneurons
Control | DA (n = 8) | Control | SKF81297 (n = 6) | Control | Quinpirole (n = 7) | |
---|---|---|---|---|---|---|
Spike amplitude (mV) | 88 ± 3.8 | 88 ± 4.1 | NA | NA | NA | NA |
Spike width (ms) | 0.54 ± 0.06 | 0.54 ± 0.05 | NA | NA | NA | NA |
Spike threshold (mV) | −40.5 ± 4.5 | −43.3 ± 4† | −40.9 ± 3 | −43 ± 2.5* | −41.3 ± 4.1 | −40.8 ± 4 |
AHP (mV) | 18.2 ± 4.8 | 17.8 ± 3.4 | 18.9 ± 2.8 | 19.1 ± 2.7 | 17.9 ± 2.5 | 17.8 ± 2.7 |
First spike latency (ms) | 20.9 ± 3.2 | 16.3 ± 1.9* | 20.4 ± 1.9 | 15.4 ± 2† | 18.4 ± 4.2 | 18.7 ± 3.5 |
First interspike interval (ms) | 24.7 ± 5.7 | 21 ± 4.2* | 24.1 ± 5.5 | 19.8 ± 4* | 25.6 ± 4.8 | 27.4 ± 6.2 |
-
The first spike latency value taken for each cell was measured from spikes evoked by minimum depolarizing current intensity that induced one or more spikes in the control. The first inter-spike interval was measured from spikes evoked by the minimum current intensity that evoked a train of non-accommodating spikes in control. Changes in spike responses to the same current intensity pulse subsequent to drug application were then analyzed. The membrane potential was held via DC current injection at the same levels in the control and in the drug. NA, not analyzed.
-
↵* P < 0.01.
-
↵† P< 0.005.